CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
RF Non-Invasive Treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04807205
NCT04807205N/ACompleted
CompareCT.gov

Post Market Study Using The Elite IQ Device

Cynosure, Inc.·interventional·Posted Mar 19, 2021·Updated Jun 12, 2024

In Brief

A clinical study evaluating RF Non-Invasive Treatment for Hair Removal and 3 related conditions. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This is a prospective, open label, single-center clinical study to collect safety and efficacy data on the Elite iQ workstation. The intended use of the Elite iQ device used in this study is for the treatment of hair removal, pseudo folliculitis barbae, and benign vascular and pigmented lesions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHair Removal, Pseudo Folliculitis Barbae, Benign Vascular Lesion, Pigmented Lesions
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 19, 2021
Enrollment StartMar 26, 2021
Primary CompletionMar 2, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.3 years ago

Interventions

RF Non-Invasive Treatmentdevice

Self-controlled single-arm group using the Elite IQ device